Literature DB >> 25571791

Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy.

Darragh Halpenny1, Carole A Ridge2, Sara Hayes1, Junting Zheng3, Chaya S Moskowitz3, Andreas Rimner4, Michelle S Ginsberg5.   

Abstract

INTRODUCTION: The objective of this study is to identify computed tomography (CT) features of local recurrence (LR) after stereotactic body radiation therapy (SBRT) for lung cancer.
METHODS: Two hundred eighteen patients underwent SBRT for lung cancer from January 1st, 2006 to March 1st, 2011. Signs of LR recorded: opacity with new bulging margin, opacification of air bronchograms, enlarging pleural effusion, new or enlarging mass, and increased lung density at the treatment site.
RESULTS: A new bulging margin at the treatment site was the only feature significantly associated with LR (P<.005).
CONCLUSION: Most CT features classically associated with LR following conventional radiation therapy are unreliable for predicting LR following SBRT.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography; Local recurrence; Lung cancer; Stereotactic body radiation therapy

Mesh:

Year:  2014        PMID: 25571791      PMCID: PMC4547627          DOI: 10.1016/j.clinimag.2014.12.005

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  21 in total

1.  An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-06       Impact factor: 2.571

2.  Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.

Authors:  Michael I Ebright; Gregory A Russo; Avneesh Gupta; Rathan M Subramaniam; Hiran C Fernando; Lisa A Kachnic
Journal:  J Thorac Cardiovasc Surg       Date:  2013-01-12       Impact factor: 5.209

3.  Radiation-induced pulmonary change: CT findings.

Authors:  H I Libshitz; L S Shuman
Journal:  J Comput Assist Tomogr       Date:  1984-02       Impact factor: 1.826

4.  Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.

Authors:  Naomi Nakajima; Yoshifumi Sugawara; Masaaki Kataoka; Yasushi Hamamoto; Takashi Ochi; Shinya Sakai; Tadaaki Takahashi; Makoto Kajihara; Norihiro Teramoto; Motohiro Yamashita; Teruhito Mochizuki
Journal:  Ann Nucl Med       Date:  2013-01-09       Impact factor: 2.668

5.  Radiological changes after stereotactic radiotherapy for stage I lung cancer.

Authors:  Max Dahele; David Palma; Frank Lagerwaard; Ben Slotman; Suresh Senan
Journal:  J Thorac Oncol       Date:  2011-07       Impact factor: 15.609

6.  Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer.

Authors:  Neal E Dunlap; Wensha Yang; Alyson McIntosh; Ke Sheng; Stanley H Benedict; Paul W Read; James M Larner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-08-14       Impact factor: 7.038

7.  Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.

Authors:  Vikram Rao Bollineni; Joachim Widder; Jan Pruim; Johannes A Langendijk; Erwin M Wiegman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-13       Impact factor: 7.038

Review 8.  Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis.

Authors:  Yo Won Choi; Reginald F Munden; Jeremy J Erasmus; Kyung Joo Park; Woo Kyung Chung; Seok Chol Jeon; Choong-Ki Park
Journal:  Radiographics       Date:  2004 Jul-Aug       Impact factor: 5.333

9.  Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis.

Authors:  Matthias Guckenberger; Michael Allgäuer; Steffen Appold; Karin Dieckmann; Iris Ernst; Ute Ganswindt; Richard Holy; Ursula Nestle; Meinhard Nevinny-Stickel; Sabine Semrau; Florian Sterzing; Andrea Wittig; Nicolaus Andratschke
Journal:  J Thorac Oncol       Date:  2013-08       Impact factor: 15.609

10.  Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.

Authors:  Xu Zhang; Hui Liu; Peter Balter; Pamela K Allen; Ritsuko Komaki; Tinsu Pan; Hubert H Chuang; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-07       Impact factor: 7.038

View more
  11 in total

Review 1.  Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?

Authors:  Sarah A Mattonen; Aaron D Ward; David A Palma
Journal:  Br J Radiol       Date:  2016-06-20       Impact factor: 3.039

Review 2.  A survey of changing trends in modelling radiation lung injury in mice: bringing out the good, the bad, and the uncertain.

Authors:  Mohamad B Dabjan; Carolyn Ms Buck; Isabel L Jackson; Zeljko Vujaskovic; Brian Marples; Julian D Down
Journal:  Lab Invest       Date:  2016-08-01       Impact factor: 5.662

Review 3.  Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.

Authors:  Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

4.  Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis.

Authors:  Tae-Hyung Kim; Sungmin Woo; Darragh F Halpenny; Yeon Joo Kim; Soon Ho Yoon; Chong Hyun Suh
Journal:  Eur J Radiol       Date:  2020-04-07       Impact factor: 3.528

5.  Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy.

Authors:  Darragh Halpenny; Micheal Raj; Andreas Rimner; Junting Zheng; Marinela Capanu; Michelle S Ginsberg
Journal:  Eur Radiol       Date:  2019-01-28       Impact factor: 5.315

Review 6.  Surveillance imaging following definitive radiotherapy for non-small cell lung cancer: What is the clinical impact?

Authors:  Brandon A Dyer; Megan E Daly
Journal:  Semin Oncol       Date:  2018-02-09       Impact factor: 4.929

7.  Quantitative texture analysis on pre-treatment computed tomography predicts local recurrence in stage I non-small cell lung cancer following stereotactic radiation therapy.

Authors:  Carole Dennie; Rebecca Thornhill; Carolina A Souza; Cecilia Odonkor; Jason R Pantarotto; Robert MacRae; Graham Cook
Journal:  Quant Imaging Med Surg       Date:  2017-12

8.  Pre-treatment CT imaging in stage IIIA lung cancer: Can we predict local recurrence after definitive chemoradiotherapy?

Authors:  Andrew J Plodkowski; Jose Arimateia Batista Araujo-Filho; Cameron D A Simmers; Jeffrey Girshman; Micheal Raj; Junting Zheng; Andreas Rimner; Michelle S Ginsberg
Journal:  Clin Imaging       Date:  2020-07-17       Impact factor: 1.605

9.  CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy.

Authors:  Qian Li; Jongphil Kim; Yoganand Balagurunathan; Jin Qi; Ying Liu; Kujtim Latifi; Eduardo G Moros; Matthew B Schabath; Zhaoxiang Ye; Robert J Gillies; Thomas J Dilling
Journal:  Radiat Oncol       Date:  2017-09-25       Impact factor: 3.481

Review 10.  Evaluation of tumor response after stereotactic body radiation therapy for lung cancer: Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Authors:  Pino Alcantara; Beatriz Cabeza Martínez; Marta García García-Esquinas; Laura G Belaústegui; Ana Bustos
Journal:  J Clin Transl Res       Date:  2020-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.